STSJMOG-ePRO
Only those who participate in the Monitoring study using ePRO in patients undergoing chemotherapy for advanced soft tissue sarcoma are eligible.
Developer: Accelight Inc.
App Size: Varies With Device
Release Date: Feb 16, 2023
Price: Free